Biblio
Export 327 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is I [Clear All Filters]
“Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1301-1340, 2017.
, “Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1327-1333, 2017.
, “The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.”, J Alzheimers Dis, vol. 59, no. 2, pp. 421-432, 2017.
, “Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 877-887, 2017.
, “Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 877-887, 2017.
, “Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 753-762, 2017.
, “Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 57, no. 2, pp. 461-473, 2017.
, “Meditation and Music Improve Memory and Cognitive Function in Adults with Subjective Cognitive Decline: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 3, pp. 899-916, 2017.
, “Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.”, J Alzheimers Dis, vol. 60, no. 2, pp. 401-425, 2017.
, “Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.”, J Alzheimers Dis, vol. 60, no. 2, pp. 401-425, 2017.
, “A Meta-Analysis of Memantine for Depression.”, J Alzheimers Dis, vol. 57, no. 1, pp. 113-121, 2017.
, “Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.”, J Alzheimers Dis, vol. 59, no. 1, pp. 121-130, 2017.
, “The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.”, J Alzheimers Dis, vol. 56, no. 3, pp. 929-938, 2017.
, “Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”, J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.
, “mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1015-1036, 2017.
, “A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
, “A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
, “Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.”, J Alzheimers Dis, vol. 59, no. 2, pp. 445-466, 2017.
, “Neural Basis of Apathy in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1403-1416, 2017.
, “Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 58, no. 3, pp. 661-667, 2017.
, “Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1153-1169, 2017.
, “Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms.”, J Alzheimers Dis, vol. 59, no. 1, pp. 141-153, 2017.
, “Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1045-1055, 2017.
, “PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.”, J Alzheimers Dis, vol. 59, no. 1, pp. 313-328, 2017.
, “Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 977-987, 2017.
,